Bladder Cancer - Results from #90

REVIEW UroToday

Topography and Lateralization of Nodal Metastases in Muscle-Invasive Bladder Cancer Using Super-Extended Pelvic Lymph Node Dissection with the Sentinel Lymph Node Technique. September 19, 2024

Implementation of Cone Beam Computed Tomography-Guided Online Adaptive Radiotherapy for Challenging Trimodal Therapy in Bladder Preservation: A Report of Two Cases. September 19, 2024

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer. September 18, 2024

Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer. September 18, 2024

An evaluation of durvalumab across the spectrum of urothelial carcinoma. September 18, 2024

Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT. September 18, 2024

"…I Wish Someone Told Me About That…": A Qualitative Assessment of the Educational Needs of Patients Undergoing Cystectomy. September 17, 2024

The prognostic significance of circulating tumor DNA in patients with positive lymph node disease after robotic-assisted radical cystectomy: A contemporary analysis. September 17, 2024

Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database. September 16, 2024

Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer. September 16, 2024

Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial Cancer. September 16, 2024

Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study. September 16, 2024

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma September 15, 2024

Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. September 13, 2024

Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints. September 13, 2024

The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancer. September 12, 2024

Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer. September 12, 2024

Urinary mRNA-based biomarkers for non-muscle-invasive bladder cancer: a mini-review. September 12, 2024

First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer. September 11, 2024

Stent vs Stent-Less Ileal Conduits After Radical Cystectomy: Is There a Difference in Early Postoperative Outcomes? September 11, 2024

Page 5 of 517